Q: Good morning. Looks LLY is going to take a bit of a hit this morning. What are your thoughts on the company and it's growth potential. I have little Healthcare exposure. Would you consider this or prefer something else?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: My healthcare stocks include ABBV,VEEV,and Well.I am considering switching from VEEV to STRYKER. What do you think?
Q: Would you get rid of Jazz. What do you think of their unusual recent acquisition? Thanks.
Q: With Mindmeds move from OTC in the USA to the Nasdaq does this change your feelings on this new potential bio space? Once listed on Nasdaq in your opinion does this give more validation to the company? Lastly would the shares on the NEO mirror the Nasdaq listing as it starts to trade?
Q: I was interested in Jeff's follow-up comment on Excelon sales declining. Who sold it before Knight in Latam and Canada? Perhaps the reason the company made a deal with Knight is to improve visibility and awareness while giving Knight's sales force new avenues for it's other products.
The price tag does not appear to be a bargain (Knight paid $360M or double for $250M sales in Biotoscan). Surely Goodman sees value in this deal. If there was no effort before then potential must be factored in and I suspect Latam is the more coveted marketplace. Can you comment and provide any previous history with sales of this product. Alzheimers us unfortunately, not going anywhere soon.
The price tag does not appear to be a bargain (Knight paid $360M or double for $250M sales in Biotoscan). Surely Goodman sees value in this deal. If there was no effort before then potential must be factored in and I suspect Latam is the more coveted marketplace. Can you comment and provide any previous history with sales of this product. Alzheimers us unfortunately, not going anywhere soon.
-
Medical Facilities Corporation (DR)
-
NorthWest Healthcare Properties Real Estate Investment Trust (NWH.UN)
-
WELL Health Technologies Corp. (WELL)
-
Dialogue Health Technologies Inc. (CARE)
Q: Hi,
How would you rank the companies in regards to financial risk and growth?
Thank you
How would you rank the companies in regards to financial risk and growth?
Thank you
Q: Just a further comment to James' question and your answer regarding the Exelon purchase. This purchase left me scratching my head. I am a healthcare provider who works in the area where Exelon would be used. I don't see much Exelon used. As you indicated, it is a mature product. However, revenues have been declining over several years, at least according to Macrotrends (available at https://www.macrotrends.net/stocks/charts/EXC/exelon/revenue) so I don't know what rabbit GUD can pull out to wring increased revenues from this medication.
Q: Hello,
In a follow up to my prior question. Can you please give your specific take with respect to the specific issues outlined in the short report. I am aware that it may require some research so please feel free to take your time in response to this question.
- divesture of Silicon Valley buyer
- data breaches
- CRH key customer renewal not looking good
- the outbidding of itself for key assets like source 44
- circle’s shareholders cashing out.
In a follow up to my prior question. Can you please give your specific take with respect to the specific issues outlined in the short report. I am aware that it may require some research so please feel free to take your time in response to this question.
- divesture of Silicon Valley buyer
- data breaches
- CRH key customer renewal not looking good
- the outbidding of itself for key assets like source 44
- circle’s shareholders cashing out.
Q: a lot of discussions today on why WELL is so bad, yet today TD upgraded stock price from $10 to $10.50 ... is this simply showing symbolic support based on their DD, or am I reading to much into this upgrade
Q: WELL is sinking like a rock based on this short report. Grizzlyreports.com/we-believe-well-health-technologies-is-a-toxic-roll-up
What are you thoughts on the issues:
- divesture of Silicon Valley buyer
- data breaches
- CRH key customer renewal not looking good
- the outbidding of itself for key assets like source 44
- circle’s shareholders cashing out.
- etc
What are you thoughts on the issues:
- divesture of Silicon Valley buyer
- data breaches
- CRH key customer renewal not looking good
- the outbidding of itself for key assets like source 44
- circle’s shareholders cashing out.
- etc
Q: Hello 5i,
What is your take on the Knight Theraputics deal and thoughts on the stock in general? Is it a buy here?
What is your take on the Knight Theraputics deal and thoughts on the stock in general? Is it a buy here?
Q: There is currently a lot of selling pressure with this stock. Is there a way to tell it could be a short attack and do you think it is.
Q: good morning - i want to increase my US health care exposure. At this point I could add to my ABBV which would make it more than a full position or I could trim a bit of ABBV and add the proceeds to existing cash to take a second US position. I do have WELL on the canadian side of my health investing. Is there a strong second US candidate you would suggest? Thanks
Q: Hello your thoughts on Guardant Health
Q: Since its last financing @ $9.80(all paid by billionarie Mr K.S.Li & his rich friends),CRH has declined to current $7(near its other $6.75 financing partially funded by Mr Li) Have a 3.5% position,p/p $8.37.Add or hold.Please comment.Txs for u usual great views & services
Q: What is your outlook for PRN? Is this a buy at current levels or do you see better opportunities in this area?
Q: Hi 5i,
ISRG reported earnings yesterday....how were they and what is your opinion on share price going forward?
Would you continue to hold or add at this point for a 2 year hold.
Thx
jim
ISRG reported earnings yesterday....how were they and what is your opinion on share price going forward?
Would you continue to hold or add at this point for a 2 year hold.
Thx
jim
Q: Hello
Can I have you opinion on this company please. Thank you
Can I have you opinion on this company please. Thank you
Q: May I have your full analysis and thoughts on the new IPO Dialogue Health Technologies Inc? Since I own TDOC in the US and Well per your recommendation (tyvm), I was thinking of switching WELL for CARE. Thank you!
Q: Bionano Genomics has been giving mixed messages. Their field looks promising, yet the stock price keeps falling. Street consensus shows a strong buy. Should I hold or sell. Thanks for the excellent service and a ton of good advice.